Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1533-1540

  Stadheim, Terrance A ^a   Xiao, Helen ^a,b   Eastman, Alan ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PACLITAXEL; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; VINBLASTINE;

APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CELL CYCLE; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKEMIA, MYELOID; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PACLITAXEL; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0035866406     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Mechanism of inhibition of cell proliferation by Vinca alkaloids
2. Vinblastine suppresses dynamics of individual microtubules in living interphase cells
3. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells
4. Identification of 2 serine residues of MEK-1 that are differentially phosphorylated during activation by raf and MEK kinase
5. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
6. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1
7. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
8. MST/MLK2, a member of the mixed lineage kinase family, directly phosphorylates and activates SEK1, an activator of c-Jun N-terminal kinase/stress-activated protein kinase
9. A novel SAPK/JNK kinase, MKK7, stimulated by TNF-α and cellular stresses
10. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat
11. The role of c-Jun N-terminal kinase in apoptosis induced by, ultraviolet C, and γ radiationduration of JNK activation may determine cell death and proliferation
12. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells
13. MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner
14. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms
15. Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade
16. Characterization of the structure and function of a novel MAP kinase kinase (MKK6)
17. Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK)
18. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells
19. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways
20. MEK kinase 1 (MEKK1) transduces c-Jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton
21. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells
22. Cleavage and nuclear translocation of the caspase 3 substrate Rho GDP-dissociation inhibitor. D4-GD1, during apoptosis
23. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration
24. Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis
25. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
26. Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis
27. A synthetic inhibitor of the mitogen-activated protein kinase cascade
28. A mammalian scaffold complex that selectively mediates MAP kinase activation
29. Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemia
30. Molecular cloning of multiple splicing variants of JIP-I preferentially expressed in brain
31. IBI reduces cytokine-induced apoptosis of insulin-secreting cells
32. A cytolasmic inhibitor of the JNK signal transduction pathway
33. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site
34. One-way cross-talk between p38(MAPK) and p42/44(MAPK)
35. Role of c-Jun N-terminal kinase/p38 stress signaling in 1-β-D-arabinofuranosylcytosine-induced apoptosis
36. Humanization of an anti-p185HER2 antibody for human cancer therapy
37. The epidermal growth factor receptor as a target for therapy in breast carcinoma
38. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
39. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-β-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling
40. Differential involvement of MEK kinase 1 (MEKK1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents
41. 2-terminal kinase/activation protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxelmediated apoptosis in human B lymphoblasts
42. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells
43. Mitogen-activated protein kinase pathway is dispensable for microtubule-active, drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells
44. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
45. The regulation of anoikis: MEKK- 1 activation requires cleavage by caspases
46. Fas-induced proteolytic activation and intracellular redistribution of the stress-signaling kinase MEKK1